Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury

Nature Medicine

Volumn 10, Issue 4, 2004, Pages 389-395

  Demjen, Deana ^a   Klussmann, Stefan ^a   Kleber, Susanne ^a   Zuliani, Cecilia ^a   Stieltjes, Bram ^a   Metzger, Corinna ^a   Hirt, Ulrich A ^b   Walczak, Henning ^b   Falk, Werner ^c   Essig, Marco ^a   Edler, Lutz ^a   Krammer, Peter H ^a   Martin Villalba, Ana ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b APOGENIX GMBH   (Germany)

^c Department of Internal Medicine I ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; LIGAND; MFL 3; NEUROMODULIN; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HINDLIMB; JOINT FUNCTION; LOCOMOTION; MOUSE; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; UPREGULATION;

ANIMALS; AXONS; CELL SURVIVAL; FAS LIGAND PROTEIN; MEMBRANE GLYCOPROTEINS; MICE; NEURONS; NEUTRALIZATION TESTS; OLIGODENDROGLIA; REGENERATION; SPINAL CORD INJURIES;

ANIMALIA;

EID: 11144354396     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1007     Document Type: Article

References (50)

1. Crowe, M.J., Bresnahan, J.C., Shuman, S.L., Masters, J.N. & Beattie, M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76 (1997).
2. Martin-Villalba, A. et al. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8, 679-686 (2001).
3. Tartaglia, L.A., Ayres, T.M., Wong, G.H. & Goeddel, D.V. A novel domain within the 55 kD TNF receptor signals cell death. Cell 74, 845-853 (1993).
4. Kischkel, F.C. et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588 (1995).
5. Medema, J.P. et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804 (1997).
6. Scaffidi, C. et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687 (1998).
7. Springer, J.E., Azbill, R.D. & Knapp, P.E. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5, 943-946 (1999).
8. Li, M. et al. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience 99, 333-342 (2000).
9. Ozawa, H., Keane, R.W., Marcillo, A.E., Diaz, P.H. & Dietrich, W.D. Therapeutic strategies targeting caspase inhibition following spinal cord injury in rats. Exp. Neurol. 177, 306-313 (2002).
10. Zurita, M., Vaquero, J. & Zurita, I. Presence and significance of CD-95 (Fas/AP01) expression after spinal cord injury. J. Neurosurg. 94, 257-264 (2001).
11. Xu, J. et al. Methylprednisolone inhibition of TNF-alpha expression and NF-κB activation after spinal cord injury in rats. Brain Res. Mol. Brain Res. 59, 135-142 (1998).
12. Li, G.L., Farooque, M. & Olsson, Y. Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord. Acta Neuropathol. (Berlin) 100, 75-81 (2000).
13. Lee, Y.B. et al. Role of tumor necrosis factor-α in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol. 166, 190-195 (2000).
14. Kim, G.M. et al. Tumor necrosis factor receptor deletion reduces nuclear factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci. 21, 6617-6625 (2001).
15. Farooque, M., Isaksson, J. & Olsson, Y. Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-α-deficient mice. J. Neurotrauma 18, 105-114 (2001).
16. Casha, S., Yu, W.R. & Fehlings, M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103, 203-218 (2001).
17. Basso, D.M., Beattie, M.S. & Bresnahan, J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21 (1995).
18. Rossignol, S. & Dubuc, R. Spinal pattern generation. Curr. Opin. Neurobiol. 4, 894-902 (1994).
19. Metz, G.A., Merkler, D., Dietz, V., Schwab, M.E. & Fouad, K. Efficient testing of motor function in spinal cord injured rats. Brain Res. 883, 165-177 (2000).
20. Woolf, C.J. A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs 47, 1-9 (1994).
21. Lindenlaub, T., Teuteberg, P., Hartung, T. & Sommer, C. Effects of neutralizing antibodies to TNF-α on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res. 866, 15-22 (2000).
22. Lindsey, A.E. et al. An analysis of changes in sensory thresholds to mild tactile and cold stimuli after experimental spinal cord injury in the rat. Neurorehabil. Neural Repair 14, 287-300 (2000).
23. Scherbel, U. et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain iniury. Proc. Natl. Acad. Sci. USA 96, 8721-8726 (1999).
24. Cohen, P.L. & Eisenberg, R.A. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 13, 427-428 (1992).
25. Braun, H., Schafer, K., & Hollt, V. β111 tubulin-expressing neurons reveal enhanced neurogenesis in hippocampal and cortical structures after a contusion trauma in rats. J. Neurotrauma 19, 975-983 (2002).
26. Fournier, A.E. & McKerracher, L. Expression of specific tubulin isotypes increases during regeneration of injured CNS neurons, but not after the application of brain-derived neurotrophic factor (BDNF). J. Neurosci. 17, 4623-4632 (1997).
27. Shackelford, D.A. & Nelson, K.E. Changes in phosphorylation of tau during ischemia and reperfusion in the rabbit spinal cord. J. Neurochem. 66, 286-295 (1996).
28. Davies, S.J. et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390, 680-683 (1997).
29. Fernandes, K.J., Fan, D.P., Tsui, B.J., Cassar, S.L. & Tetzlaff, W. Influence of the axotomy to cell body distance in rat rubrospinal and spinal motoneurons: differential regulation of GAP-43, tubulins, and neurofilament-M. J. Comp. Neurol. 414, 495-510 (1999).
30. Shuman, S.L., Bresnahan, J.C. & Beattie, M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 50, 798-808 (1997).
31. Dong, H. et al. Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration, J. Neurosci. 23, 8682-8691 (2003).
32. D'Souza, S.D. et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184, 2361-2370 (1996).
33. Becher, B., D'Souza, S.D., Troutt, A.B., & Antel, J.P. Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity, Neuroscience 84, 627-34 (1998).
34. Li, W. et al. Apoptotic death following Fas activation in human oligodendrocyte hybrid cultures. J. Neurosci. Res. 69, 189-196 (2002).
35. Casha, S., Yu, W.R. & Fehlings, M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103, 203-218 (2001).
36. Desbarats, J. et al. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118-125 (2003).
37. Martin-Villalba, A. et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809-3817 (1999).
38. Raoul, C., Henderson, C.E. & Pettmann, B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147, 1049-1062 (1999).
39. Ugolini, G. et al. Fas/tumor necrosis factor receptor death signaling is required for axotomy-induced death of motoneurons in vivo. J. Neurosci. 23, 8526-8531 (2003).
40. Brosamle, C., Huber, A.B., Fiedler, M., Skerra, A. & Schwab, M.E. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J. Neurosci. 20, 8061-8068 (2000).
41. GrandPre, T., Li, S. & Strittmatter, S. M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417, 547-551 (2002).
42. Moon, L.D., Asher, R.A., Rhodes, K.E. & Fawcett, J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4, 465-466 (2001).
43. Grill, R.J., Blesch, A. & Tuszynski, M.H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 148, 444-452 (1997).
44. Thallmair, M. et al. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat. Neurosci. 1, 124-131 (1998).
45. Lehmann, M. et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19, 7537-7547 (1999).
46. Neumann, S., Bradke, F., Tessier-Lavigne, M. & Basbaum, A.I. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 34, 885-893 (2002).
47. Qiu, J. et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 34, 895-903 (2002).
48. Ramon-Cueto, A., Plant, G.W., Avila, J. & Bunge, M.B. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18, 3803-3815 (1998).
49. Shi, R. & Blight, A.R. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord, Neuroscience 77, 553-562 (1997).
50. Echtenacher, B., Falk, W., Mannel, D.N. & Krammer, P.H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145, 3762-3766 (1990).